A study on childhood ALL evaluated the role of a genetic polymorphism (glutathione S-transferase- θ, GST-T1) on treatment failure due to relapse (in different sites), in the presence of a competing event (toxic death). The gene discussed is HPGDS; the disease is acute lymphoblastic leukemia.